Season 25 · Episode 66
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Hematologic Oncology Update · Dr. Neil Love
February 18, 202657m 58s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.